APRIL GALLIK: Open Payments
NPI 1134720436 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 54 payments from 15 companies in 2025. Trend: 2023 $127 · 2024 $0 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $225 |
| ABBVIE INC. | 9 | $171 |
| Exact Sciences Corporation | 3 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| Novo Nordisk Inc | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 1 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| SANOFI-AVENTIS U.S. LLC | 2 | $61 |
| Corcept Therapeutics | 2 | $54 |
Products named: The Cologuard Plus Collection Kit, MOUNJARO, CAPLYTA, LINZESS, Rybelsus, VOQUEZNA, Kerendia, TZIELD.
Industry payments across IL — which companies pay providers there.
